Postoperative adjuvant chemotherapy for non-small cell lung cancer

Tatsuro Okamoto, Yukito Ichinose

研究成果: Contribution to journalReview article査読

抄録

Patients with completely resected non-small-cell lung cancer (NSCLC) are subjects for postoperative adjuvant treatment. Recently, several randomized trials with a large number of enrolled patients have shown that platinum-based chemotherapy has potential for improving survival among patients with completely resected NSCLC in Western countries. In Japan, uracil-tegafur was also shown to improve survival among patients with completely resected stage I adenocarcinoma. This review evaluated the role of adjuvant chemotherapy, based on the results of randomized trials and meta-analyses.

本文言語英語
ページ(範囲)765-769
ページ数5
ジャーナルGan to kagaku ryoho. Cancer & chemotherapy
32
6
出版ステータス出版済み - 1 1 2005

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

フィンガープリント 「Postoperative adjuvant chemotherapy for non-small cell lung cancer」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル